Bürki K - Search Results

1

Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center.

Joss RA, Bürki K, Dalquen P, Schatzmann E, Leyvraz S, Cavalli F, Ludwig C, Siegenthaler P, Alberto P, Stahel R, et al. Joss RA, et al. Among authors: burki k. Cancer. 1990 Jun 1;65(11):2426-34. doi: 10.1002/1097-0142(19900601)65:11<2426::aid-cncr2820651104>3.0.co;2-3. Cancer. 1990. PMID: 2159837 Clinical Trial.

2

ABLETOP, a well-tolerated, effective regimen for relapsing Hodgkin's disease. Swiss Group for Clinical Cancer Research (SAKK).

Obrist R, Honegger HP, Aapro M, Bürki K, Cavalli F. Obrist R, et al. Among authors: burki k. Onkologie. 1989 Apr;12(2):99-101. doi: 10.1159/000216610. Onkologie. 1989. PMID: 2471947 Clinical Trial.

3

2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma.

Betticher DC, Zucca E, von Rohr A, Egger T, Radford JA, Ambrosetti A, Bürki K, Rufener B, Schmitz SF, Cerny T. Betticher DC, et al. Among authors: burki k. Ann Oncol. 1996 Oct;7(8):793-9. doi: 10.1093/oxfordjournals.annonc.a010757. Ann Oncol. 1996. PMID: 8922192 Free article. Clinical Trial.

4

Pathologic data of prognostic significance for remission induction in advanced ovarian carcinoma.

Davis BW, Goldhirsch A, Locher GW, Dreher E, Greiner R, Burki K, Brunner KW. Davis BW, et al. Among authors: burki k. J Cancer Res Clin Oncol. 1984;107(2):106-10. doi: 10.1007/BF00399381. J Cancer Res Clin Oncol. 1984. PMID: 6325466

5

The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).

Ghielmini M, Schmitz SF, Bürki K, Pichert G, Betticher DC, Stupp R, Wernli M, Lohri A, Schmitter D, Bertoni F, Cerny T. Ghielmini M, et al. Among authors: burki k. Ann Oncol. 2000;11 Suppl 1:123-6. Ann Oncol. 2000. PMID: 10707793 Clinical Trial.

6

Recurrent cutaneous anaplastic large cell (CD30+) lymphoma associated with Epstein-Barr virus. A case report with 9-year follow-up.

Borisch B, Böni J, Bürki K, Laissue JA. Borisch B, et al. Among authors: burki k. Am J Surg Pathol. 1992 Aug;16(8):796-801. doi: 10.1097/00000478-199208000-00009. Am J Surg Pathol. 1992. PMID: 1323224

7

Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement.

Borisch B, Hennig I, Horber F, Bürki K, Laissue J. Borisch B, et al. Among authors: burki k. Virchows Arch A Pathol Anat Histopathol. 1992;421(5):443-7. doi: 10.1007/BF01606918. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1333679

8

Heterogeneous malignant non Hodgkin's lymphomas as a causative disorder in lethal midline granuloma.

Laeng RH, Gerber HA, Schaffner T, Bürki KH. Laeng RH, et al. Among authors: burki kh. Virchows Arch A Pathol Anat Histopathol. 1989;415(3):265-73. doi: 10.1007/BF00724914. Virchows Arch A Pathol Anat Histopathol. 1989. PMID: 2527438

9

[Large cell anaplastic lymphomas in the immunocompromised host].

Borisch B, Fey MF, Tobler A, Bürki K, Gatter KC, Wainscoat JS. Borisch B, et al. Among authors: burki k. Verh Dtsch Ges Pathol. 1991;75:171-4. Verh Dtsch Ges Pathol. 1991. PMID: 1724824 German.

10

[Behavior of mouse spleen germinal center cells after secondary stimulation with tetanus toxoid injected into the footpads. Radiographic studies with thymidine-3H].

Lewerenz M, Laissue J, Bürki H, Bürki K. Lewerenz M, et al. Among authors: burki h, burki k. Virchows Arch B Cell Pathol. 1969;2(3):203-19. Virchows Arch B Cell Pathol. 1969. PMID: 4978206 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters